Journal profile
Nuclear Receptor Research
ISSN 2314-5706 · eISSN 2314-5714 · KenzPub · Egypt
Nuclear Receptor Research: fully open access; review about 12 weeks (community reports); 0 articles in 2025.
Scope
Aims, scope and focus
Nuclear Receptor Research is published by KenzPub. By OpenAlex counts of its recent articles, its largest topics are Estrogen and related hormone effects, Peroxisome Proliferator-Activated Receptors and Nuclear Receptors and Signaling, together about 39.3% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Estrogen and related hormone effectsBiochemistry, Genetics and Molecular Biology14.8%
- Peroxisome Proliferator-Activated ReceptorsBiochemistry, Genetics and Molecular Biology12.3%
- Nuclear Receptors and SignalingNeuroscience12.3%
- Drug Transport and Resistance MechanismsMedicine8.2%
- Computational Drug Discovery MethodsComputer Science6.6%
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics5.7%
- Cholesterol and Lipid MetabolismMedicine4.9%
- Protein Structure and DynamicsBiochemistry, Genetics and Molecular Biology3.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
Indexed in: no record yet.
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 15OpenAlex ·
- i10-index
- 23OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 60 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 56 |
| 2025 | 0 | 0 | 73 |
| 2024 | 0 | 0 | 85 |
| 2023 | 0 | 0 | 100 |
| 2022 | 0 | 0 | 134 |
| 2021 | 0 | 0 | 150 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 12 weeksLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- KenzPub
- Country or region
- Egypt
- Language
- English
- ISSN
- 2314-5706
- Electronic ISSN
- 2314-5714
- Official links
- Journal homepage ↗LetPub
FAQ
Frequently asked questions about Nuclear Receptor Research
How long does peer review take at Nuclear Receptor Research?
Authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Is Nuclear Receptor Research open access, and what is the APC?
Nuclear Receptor Research is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .